At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.6B, above the global median of $1.14B
- FinancialsAltman Z-Score 1.89: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.53%Below 5Y avg (0.70%)
Annual Rate
INR 5.00Paid annual
Payout Ratio
22.5%Sustainable
Last Ex-Dividend
Jul 24, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
149.52BINR1.60B · vs all stocks (USD)
Trailing P/E
42.58xRevenue (TTM)
86.08BINR918.85M · vs all stocks (USD)
Profit Margin
4.09%Beta
0.4650xvs all stocks
52-Week Change
-15.33%vs all stocks
Market Capitalization
149.52BINR1.60B · vs all stocks (USD)
Enterprise Value
175.52BINR1.87B · vs all stocks (USD)
Trailing P/E
42.58xForward P/E
18.67xPEG Ratio
-0.6733xPrice to Sales (TTM)
1.74xPrice to Book (MRQ)
2.11xEnterprise to Revenue
2.04xEnterprise to EBITDA
16.48xGross Margin
66.29%Profit Margin
4.09%Operating Margin
5.41%Return on Assets (TTM)
2.57%Return on Equity (TTM)
5.62%Revenue (TTM)
86.08BINR918.85M · vs all stocks (USD)
Revenue per Share (TTM)
543.43INRUpdated Oct 29, 2026Quarterly Revenue Growth
17.30%Gross Profit (TTM)
55.94BINR597.05M · vs all stocks (USD)
EBITDA (TTM)
12.42BINR132.60M · vs all stocks (USD)
Net Income (TTM)
3.52BINR37.58M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-45.10%Operating Cash Flow (TTM)
12.27BINR130.95M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
3.98BINR42.54M · vs all stocks (USD)
Trailing Annual Dividend Rate
5.00INRUpdated Oct 29, 2026Trailing Annual Dividend Yield
0.53%vs all stocks
5-Year Average Dividend Yield
0.70%vs all stocks
Payout Ratio
22.55%Minority Interest (Equity)
28.00MINRFY2026 · Mar 31, 2026Revenue
82.25BINRFY2026 · Mar 31, 2026Cost of Goods Sold
29.91BINRFY2026 · Mar 31, 2026Gross Profit
52.34BINRFY2026 · Mar 31, 2026Operating Income
8.19BINR87.46M · vs all stocks (USD)
Pre-tax Income
6.14BINRFY2026 · Mar 31, 2026Income Tax Expense
2.17BINRFY2026 · Mar 31, 2026Net Income
3.98BINRFY2026 · Mar 31, 2026EBIT
8.15BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
13.12BINRFY2026 · Mar 31, 2026Selling, General & Administrative
4.64BINRFY2026 · Mar 31, 2026Other Operating Expenses
8.09BINRFY2026 · Mar 31, 2026Non-operating Interest Income
252.00MINRFY2026 · Mar 31, 2026Non-operating Interest Expense
2.01BINRFY2026 · Mar 31, 2026EPS (Basic)
25.15INRFY2026 · Mar 31, 2026EPS (Diluted)
25.08INRFY2026 · Mar 31, 2026Basic Shares Outstanding
158.48MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
158.48MSharesFY2026 · Mar 31, 2026Minority Interests (P&L)
10.00MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
8.90BINRFY2026 · Mar 31, 2026Free Cash Flow
-4.57BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
12.67BINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
6.14BINRFY2026 · Mar 31, 2026Stock-based Compensation
118.00MINRFY2026 · Mar 31, 2026Other Non-cash Items
2.34BINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-1.05BINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
1.34BINRFY2026 · Mar 31, 2026Capital Expenditures
-13.47BINRFY2026 · Mar 31, 2026Purchase of Investments
-179.00MINRFY2026 · Mar 31, 2026Sale of Investments
14.00MINRFY2026 · Mar 31, 2026Other Investing Activity
791.00MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-12.84BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
25.71BINRFY2026 · Mar 31, 2026Long-term Debt Payments
-20.13BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
-565.00MINRFY2026 · Mar 31, 2026Common Stock Repurchase
-187.00MINRFY2026 · Mar 31, 2026Common Dividends Paid
-795.00MINRFY2026 · Mar 31, 2026Other Financing Charges
-3.00MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
4.04BINRFY2026 · Mar 31, 2026Shares Outstanding
158.41MSharesUpdated Oct 29, 2026Float Shares
70.18MSharesUpdated Oct 29, 2026% Held by Insiders
56.23%vs all stocks
% Held by Institutions
24.33%vs all stocks
Total Cash (MRQ)
12.67BINR135.25M · vs all stocks (USD)
Total Cash per Share (MRQ)
80.00INRUpdated Oct 29, 2026Total Debt (MRQ)
36.15BINR385.83M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5094xCurrent Ratio (MRQ)
1.62xBook Value per Share (MRQ)
447.81INRUpdated Oct 29, 2026Total Assets
155.23BINR1.66B · vs all stocks (USD)
Total Current Assets
41.09BINRFY2026 · Mar 31, 2026Total Liabilities
84.27BINRFY2026 · Mar 31, 2026Total Non-current Assets
114.13BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
58.88BINRFY2026 · Mar 31, 2026Total Current Liabilities
25.39BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
12.67BINRFY2026 · Mar 31, 2026Other Short-term Investments
2.19BINRFY2026 · Mar 31, 2026Accounts Receivable
10.70BINRFY2026 · Mar 31, 2026Inventory
12.31BINRFY2026 · Mar 31, 2026Accounts Payable
12.34BINRFY2026 · Mar 31, 2026Short-term Debt
3.15BINRFY2026 · Mar 31, 2026Other Current Liabilities
3.40BINRFY2026 · Mar 31, 2026Long-term Debt
33.00BINRFY2026 · Mar 31, 2026Other Non-current Liabilities
13.72BINRFY2026 · Mar 31, 2026Common Stock (Book)
158.00MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
70.96BINR757.38M · vs all stocks (USD)
52-Week Low
786.05INRUpdated Oct 29, 202652-Week High
1.18KINRUpdated Oct 29, 202652-Week Change
-15.33%vs all stocks
Beta
0.4650xvs all stocks
50-Day MA
963.36INRUpdated Oct 29, 2026200-Day MA
942.16INRUpdated Oct 29, 2026Avg 10-Day Volume
149.71KSharesUpdated Oct 29, 2026Avg 30-Day Volume
265.27KSharesUpdated Oct 29, 2026Diluted EPS (TTM)
22.17INRUpdated Oct 29, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.66Profit Margin: 0.04
Financial Health
Altman Z-Score 1.89: grey zoneSignificant
Altman Z-Score: 1.89
High earnings qualityNotable
Earnings Quality Score: 0.57
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.6B, above the global median of $1.14BNotable
Market cap (USD): 1,595,996,292.716Global Median: 1,137,180,293.291
Revenue is $918.85M, above the global median of $566.17MNotable
Revenue (USD): 918,849,967.276Global Median: 566,172,992
Levered free cash flow is $42.54M, above the global median of $18.58MNotable
Levered free cash flow (USD): 42,535,890Global Median: 18,579,867.004
Companies that share the same coordination system — how they create, deliver, or capture value.
Alembic Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nuvation Bio Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Pharmablock Sciences Nanjing Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Consun Pharmaceutical Group Limited
Tier 1ProductionApproval-Gated PipelineRule
Shanghai MicroPort Endovascular MedTech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Natco Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Qingdao Haier Biomedical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zhejiang Conba Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Yifan Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
MeHow Innovative Ltd.
Tier 1ProductionApproval-Gated PipelineRule